Skip to main content

Table 3 Glomerular and tubular functional assessment and combined marker analyses a

From: Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds

 

Mean (95% CI) (present study)

Healthy volunteers bmean (SD)

 

ml/min/1.73 m 2

ml/min

ml/min

Glomerular filtration rate (n =15)

161 (129 to 193)

180 (141 to 219)

143 (45)

Effective renal plasma flow (n =19)

535 (442 to 628)

594 (484 to 704)

467 (146)

Renal tubular anion secretion (n =15)

   

Net secretion of PAH

388 (282 to 494)

428 (306 to 550)

359 (134)

Renal tubular cation secretion (n =10)

   

Net tubular secretion of (S)-pindolol

47 (−19 to 113)

46 (−15 to 107)

152 (70)

Net tubular secretion of (R)-pindolol

25 (−16 to 67)

24 (−17 to 66)

132 (45)

Renal tubular reabsorption (n =13)

   

Net tubular reabsorption of fluconazole

120 (92 to 148)

135 (100 to 169)

93 (29)

  1. aCI, Confidence interval; PAH, p-Aminohippuric acid; SD, Standard deviation. bTwelve healthy male subjects (mean age, 24 years; mean weight, 72 kg; mean height, 1.78 m) with normal laboratory parameters and a Cockcroft-Gault estimated creatinine clearance >100 ml/min [9].